National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

buthionine sulfoximine
A synthetic amino acid. Buthionine sulfoximine irreversibly inhibits gamma-glutamylcysteine synthetase, thereby depleting cells of glutathione, a metabolite that plays a critical role in protecting cells against oxidative stress, and resulting in free radical-induced apoptosis. Elevated glutathione levels are associated with tumor cell resistance to alkylating agents and platinum compounds. By depleting cells of glutathione, this agent may enhance the in vitro and in vivo cytotoxicities of various chemotherapeutic agents in drug-resistant tumors. Buthionine sulfoximine may also exhibit antiangiogenesis activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:d,l-buthionine-s,r-sulfoximine
L-buthionine sulfoximine
Abbreviation:BSO
Chemical structure names:
  • 2-amino-4-(S-butylsulfonimidoyl) butanoic acid
  • butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-
  • S-(3-amino-3-carboxypropyl)-S-butylsulfoximine
  • S-(n-butyl)homocysteine sulfoximine



Previous:buserelin, Buspar, buspirone hydrochloride, busulfan, Busulfex
Next:C-11 choline, c-Met inhibitor ARQ 197, c-Met inhibitor JNJ-38877605, c-myb antisense oligonucleotide G4460, CAF regimen

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov